In KCs, the expression of EGFR and IFRD1 are tightly linked, as EGFR inhibition reduced the expression and protein levels of IFRD1, via mTOR, RAF and/or MEK1, but not PI3K or JNK. Here, MAP2K1 is linked to dry eye syndrome.